Glaucoma is the second-leading cause of blindness after cataracts. Often called the “silent thief of sight” because the debilitating loss of vision occurs gradually, glaucoma is expected to affect over 79 million people globally by 2020.
Prompt diagnosis of glaucoma is extremely important to making appropriate treatment decisions and it’s never too early to identify the signs. But the slow onset of glaucoma means the disease often goes unnoticed until it’s too late.
The NuCoria Visual Field Analyzer (nCFA), is a joint development by Seeing Machines and a team from the Australian National University.
Unlike traditional diagnostic methods that rely on subjective patient feedback, NuCoria utilizes our patented eye tracking algorithms mixed with advanced light stimulation to measure microscopic involuntary changes of the pupil—without any patient input. With a greatly reduced margin of error, NuCoria helps to identify—and prevent—glaucoma in those pivotal early stages of development.
Significant studies on NuCoria’s utility for identifying the other major blinding diseases, as well as certain neurological disorders could see the nCFA become a major medical breakthrough.